Target intelligence / Profile preview

Blood–brain barrier structural proteins

Molecular classification
Structural protein, Tight junction protein, Junctional adhesion molecule, Scaffolding protein, Adherens junction protein
01

Overview

Blood–brain barrier structural proteins are a group of proteins—including tight junction proteins (e.g., Claudins, Occludins), junctional adhesion molecules (JAMs), and scaffolding proteins (e.g., ZO-1)—that seal the spaces between endothelial cells in brain microvasculature, forming a highly selective and semipermeable barrier between the blood and brain tissue. These proteins prevent unwanted solute passage, maintain CNS homeostasis, and contribute to the protective neurovascular unit. Dysfunction or alteration in these proteins is implicated in numerous neurologic diseases, and while individual structural proteins may be drug targets or biomarkers, the collective group does not constitute a typical molecular target for therapeutic intervention.

02

Biological functions

Paracellular barrier formationMaintenance of central nervous system homeostasisRegulation of permeability/selective solute transport across BBBFacilitation of cell–cell adhesion in the neurovascular unit
03

Disease associations

Neurodegenerative diseases (e.g., Alzheimer's disease, Parkinson's disease)Tumors and cancer (altered BBB permeability in brain tumors)Multiple sclerosisIschemia/strokeInfection (BBB breakdown increases susceptibility)
04

Safety considerations

Modulating BBB integrity risks increased neurotoxicity and infection due to compromised CNS protectionDisruption may cause brain edema and elevated intracranial pressureTargeting BBB components may impact nutrient supply and waste removal in CNS

Beyond the preview

Go deeper on Blood–brain barrier structural proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood–brain barrier structural proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call